Tizanidine Hydrochloride Capsule
Product Images NDC 72789-505

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 72789-505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789505 Label (72789505)

This text provides detailed information about a medication containing tizanidine hydrochloride, with each capsule equivalent to 6 mg of tizanidine base. It includes storage instructions, prescribing information, and details of the manufacturer and distributor. The medication should be kept in containers with child-resistant closures and stored at 25°C with excursions permitted to 15° - 30°C. For further information or inquiries, contact PD-Rx Pharmaceuticals, Inc.*

FDA Label Image

Figure 1 (Tizanidine Hydrochloride Capsules Figure 1)

FDA Label Image

Figure 2 (Tizanidine Hydrochloride Capsules Figure 2)

FDA Label Image

Figure 3 (Tizanidine Hydrochloride Capsules Figure 3)

This text mentions a study involving Tizanidine and a placebo, with a mean dose of 28.8. It also discusses improvement in the Ashworth Score over the course of the study, with reference to different study weeks and endpoints. The study appears to involve titration and maintenance periods, with the last observation being carried forward for analysis.*

FDA Label Image

Chemical Structural Formula (Tizanidine Hydrochloride Capsules Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.